In a highly antipicated decision, the Court of Arbitration for Sport dismissed Floyd Landis’ appeal of his suspension related to a positive drug screening test at the 2006 Tour de France. Landis, as you may recall, was accused of using artificial testosterone after an anti-doping lab in France reported anomalous findings for a sample Landis provided after his epic ride on Stage 17 of the 2006 Tour.
In a press release issued at 5 p.m. Swiss time, the CAS panel said:
“The CAS Panel considered all arguments and evidence submitted by the parties throughout the proceedings and found that the Laboratoire National de Depistage du Dopage (LNDD), which is the laboratory which performed the analyses of Floyd Landis’ urine sample provided after stage 17 of the Tour de France 2006, did not violate the International Standard for Laboratories (ISL).”
“In particular, the panel found that:
1. The LNDD is a WADA-accredited laboratory which benefits from the presumption that it conducted sample analysisin accordance with international laboratory standards.
2. The athlete has not rebutted this presumption by showing that a departure from the International Standard occurred.”
“The Panel concluded that the presence of exogenous testosterone or its precursors or metabolites in Floyd Landis’ sample proves that he violated the anti-doping rules of the International Cycling Union.”
In addition, the panel has ordered Landis to pay $100,000 to USADA to help defray their legal costs. The full award is available here.
More coverage will appear here throughout the day, as this story develops.